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Abstract
Halogen bonding is a noncovalent interaction that continues to garner interest among the
scientific community. Investigation of halogen bonds in biological contexts typically revolves
around rational drug design for developing therapeutics. However, halogen bonding may be
occurring naturally in our body every day. Thyroid hormone and its regulating enzyme,
iodothyronine deiodinase, show promising results for a halogen bonding interaction that happens
during catalysis. Prior work has examined the interaction between the iodine of thyroid hormone
and the selenium of iodothyronine deiodinase. However, this study is the first of its kind to use
computational chemistry methods to analyze the halogen bond using the complete enzyme/ligand
complex. While halogen bonding between thyroid hormone and deiodinase cannot be confirmed
from this study, a more complex picture has been painted that alludes to the existence of such
electrostatic interaction.
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Introduction
Defining Halogen Bonding
Halogen bonding is an electrostatic chemical bonding phenomenon resulting from the
attraction between a partially positive region on a halogen atom and a negatively charged
electron-donor or base (Figure 1).1
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Figure 1. Depiction of halogen bonding. The halogen atom is shown as X and an electron
donor species is shown as Y. Partial positive potential is shown as δ+ and partial negative
potential is shown as δ-. The halogen bonding interaction between X and Y is depicted as the
three dots.
In accordance with their large electronegativity, halogen atoms are strong electronwithdrawing species, so the existence of a partially positive region on these atoms is
counterintuitive. However, the partially positive region, referred to as the s-hole, comes about
due to an electron withdrawing group to which it is bonded pulling electron density from the
halogen parallel to the R-X axis. Subsequently, the halogen atom has a nonuniform distribution
of electrostatic potential, with negative electrostatic potential building up around the atom in a
“belt”, and positive electrostatic potential at the distal tip, known as the s-hole (Figure 2).
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lllilPolarization of
electron density

8-

8Figure 2. Model of the nonuniform distribution of electron density on halogen atom. The
blue region of the halogen atom represents the partially positive potential of the s-hole. Note that
the s-hole is opposite of the R-X axis. The filled lone pairs account for the negative electrostatic
potential on the halogen perpendicular to the R-X axis.
As a result, the halogen atom can act as a Lewis acid that undergoes bonding interactions
with a Lewis base. Analogous to the hydrogen bond, the halogen bond is a non-covalent
interaction between an atom with a partial positive potential and an atom with a partial negative
potential. In the case of the hydrogen bond, the interaction results from a partially positive
hydrogen attracting a partially negative atom, such as an oxygen or a nitrogen. The size and
strength of the s-hole is directly related to the size of the halogen, with the very polarizable
iodine exhibiting the most partially positive region, followed by bromine, chlorine, and lastly
fluorine. Furthermore, the location of the s-hole on the tip of the halogen, opposite of the R-X
bond, requires a roughly 180° angle of interaction with the partially negative atom (Figure 3).
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180° angle of
interaction

5+e e e5Figure 3. 180° angle of interaction for halogen bonding. The s-hole only exists opposite of
the R-X bond axis and therefore only attracts a partially negative atom at roughly 180°.
While there are important differences between halogen and hydrogen bonding, the
electrostatic basis for both interactions draw stark comparisons. Since hydrogen bonding plays a
crucial role in the conformation of important large molecules, such as the double helix in DNA
or the secondary structure of proteins, investigating the impact of halogen bonding is
undoubtedly warranted.

History of Halogen Bonding in the Literature
Although hydrogen bonding has been of special interest to chemists and biologists for the
last century, research on halogen bonding has been relatively limited. The phenomenon of
halogen bonding has been observed since the 1800s as iodide was shown to react with ammonia
to form iodammonium.2 In the 1950s, chemists began to describe “charge-transfer” complexes in
which activation barriers for chemical reactions were reduced in a quasi-dative bonding
interaction.3 Further examinations of charge-transfer bonding brought observations of
polymerization of organic compounds with halogenated molecular bridges. A paper published in
1962 described repeating p-xylene/carbon-tetrabromide molecules, attributing the aggregation to
charge-transfer bonding between the π electrons of the aromatic ring and the bromine atoms.4 In
1970, a paper identified dioxane-bromine molecules arranged in a linear fashion with bond
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lengths shorter than the van der Waals radii.5 The strength of the charge-transfer bonds
corresponded directly with the size of the halogen, as iodine displayed the strongest interaction
while chlorine displayed the weakest.5 Alternatively, the same dioxane-bromine interaction was
described where the halogen molecule acted as an electron acceptor.6 Shorter intermolecular
distances between a halogen and a partially negative atom, along with elongated intramolecular
bonds in the halogen-containing molecule, were documented in a larger range of compounds,
including acetone, methanol, pyridine, and benzyl sulfide.6
In the early 1990s, the term “halogen bonding” began to circulate in the literature with
reference to charge-transfer bonding. Specifically, in 1992, Bruggermann and Kochi referred to
the activation of aromatic hydrocarbons by stannic chloride as “formal halogen bonding”.7 In
1998, Alkorta et al. wrote about charge-transfer complexes; however, they labeled the complexes
as halogen bonded complexes in an analogy to hydrogen bonded complexes.8 The use of the term
halogen bonding gradually became more popular with the expansion in knowledge of the
halogen’s anisotropic electrostatic potential distribution and the “sigma hole”.9 After the
identification of the s-hole, research on halogen bonding exploded. It showed promise as a
strong non-covalent intermolecular force, analogous to and even out competing hydrogen
bonding in some scenarios.10 The halogen bonding phenomenon graduated from its earlier
anonymous categorization under the general heading of charge-transfer complexes due to
arguments for the contributions of electrostatics and polarity in regards to the strength of
interactions.11 An official IUPAC definition was finalized and accepted in 2013, stating that ”a
halogen bond occurs when there is evidence of net attraction between an electrophilic region
associated with a halogen atom in a molecular entity and a nucleophilic region in another, or the
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same, molecular entity.”12 Applications of the interaction under the newly minted halogen bond
label began to surface in supramolecular chemistry, crystal engineering, and biological settings.13

Halogen Bonding in a Biological Context
When you think of halogens in biological systems, maybe the fluoride in toothpaste or
the chloride in table salt comes to mind. Accordingly, when thinking of common elements within
the body, halogens are never discussed as a fundamental part of terrestrial architecture. Unlike
carbon, nitrogen, oxygen, phosphorus, and calcium, halogens are not used by nature to constitute
biological organisms and are only present in the body in trace amounts. For this reason,
biologists did not react to the alarm bells that went off in the 1990s in the same way that
chemists did regarding the phenomenon of halogen bonding. However, roughly a decade later,
the halogen bonding shock wave finally made its way to the biological realm. In 2004, a survey
of the Protein Data Bank was published that searched for biological molecules containing at least
one C-X bond, finding 226 single-crystal structures and 87 halogenated nucleic acids.14 From
here, the authors narrowed their search for interactions that fit the current halogen bond
definition. The results found 66 proteins and 6 nucleic acid structures having X-O interactions
that fit the criteria, totaling 113 unique halogen bonding interactions.14 The list continued to
grow, and biologists began to take special interest in exploring the potential benefits of halogen
bonding in biological systems.
The halogen bond’s strict conformation, strength of interaction, and tunability make it an
attractive prospect for drug designers. By strategically incorporating a halogen atom into a
molecular design, researchers can increase interaction strength between receptors and ligands.13
The stirrings from the 2004 PDB Survey have produced a wide variety of publications within
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medicinal chemistry, particularly oncology. An article from 2012 published promising results on
reversing the inactivation of the p53 tumor suppressor through use of small molecules with
incorporated halogen bonding sites.15 Another article published in 2007 described the
incorporation of halogen bonding into the molecular engineering of protein kinase inhibitors.16
Halogen bonding was shown to cause a 20-fold increase in the binding affinity of the potential
drug to the protein kinase ATP-binding domain.16 While rational drug designers have utilized
halogens as a way to modify receptor-ligand interactions, other researchers have identified innate
halogen bonding interactions within the human body that may have large-scale implications on
human health.13

Thyroid Hormones and Iodothyronine Deiodinase
An interesting place to search for halogen bonding in the human body is with thyroid
hormones. Thyroid hormones are the only identified molecules in the body to incorporate iodine
into their structures. Thyroxine (T4) contains four iodine atoms, hence the subscript in its
abbreviation (Figure 4).

Thyroxine (T4)
(Prohormone form)
I
HO~

0
I

OH

l)l)__O
Figure 4. Structure of thyroxine. Thyroxine has an inner ring and an outer ring that each
contain two iodine atoms. The inner ring iodine atoms are referred to the 3-iodine and 5-iodine,
while the outer ring iodine atoms are the 3’-iodine and 5’-iodine. Thyroxine is the prohormone
version of thyroid hormone because it is secreted by the thyroid glands and must be activated to
produce its effects on tissue.
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Activation of T4 occurs by removing the 5’-iodine from the outer ring. The resulting
compound is called triiodothyronine, or T3. However, T4 can also be permanently inactivated by
removing the 5-iodine from the inner ring. The permanently inactive compound is called reverse
triiodothyronine, or rT3. The enzymes that remove iodine atoms from thyroid hormone are called
iodothyronine deiodinases. Three types of iodothyronine deiodinases exist in humans: type 1
deiodinase, type 2 deiodinase, and type 3 deiodinase. Type 1 and 2 deiodinase perform outer ring
deiodination, or activation of T4 to T3. Type 3 deiodinase strictly performs inner ring deiodinase,
or inactivation of T4 to rT3 (Figure 5).
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Figure 5. Different types of deiodinases and their functions. Dio1, Dio2, and Dio3 refer to
type 1, type 2, and type 3 deiodinase, respectively. Dio1 and Dio2 perform outer ring
deiodination of the 5’-iodine, effectively activating thyroxine. Dio3 only performs inner ring
deiodination of the 5-iodine, permanently inactivating thyroxine.
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Activation and inactivation of thyroid hormone functions to maintain thyroid
homeostasis. Thyroid hormone is heavily involved in controlling metabolic rates and
development in almost every organ system in the body.17 Pathologically, overactive thyroid
hormone can result in hyperthyroidism and underactive thyroid hormone can result in
hypothyroidism. Therefore, the deiodinase pathway has major implications for human health and
may be used as a tool to treat various thyroid disorders.
Bayse and Rafferty suggested that halogen bonding could be the basis for iodothyronine
deiodinase activity.18 All three types of deiodinases contain a very rare selenocysteine residue in
their active site that performs the deiodination. The selenium atom of the selenocysteine,
proposed by Bayse and Rafferty, may undergo a halogen bonding interaction with the iodine on
thyroxine. They also suggested that the rendezvous of these two very rare trace elements in such
a consequential biochemical pathway could be the result of selection due to halogen bonding.
The strong nucleophilicity of selenium, in combination with the robust σ-hole of iodine, is the
ideal scenario for halogen bonding to arise. To investigate the potential for halogen bonding,
Bayse and Rafferty used computational chemistry methods to model the interaction between
Dio1 and thyroxine. However, their model was very basic, using methyl selenol and an aryl
iodide to represent the selenocysteine residue and thyroxine, respectively. Their results did
indicate that halogen bonding does occur between iodine and selenium. Nevertheless, their
oversimplified approach serves as a barrier to the validity of any conclusions on whether a
halogen bonding occurs in the interaction between deiodinase and thyroxine.
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Taking a Different Approach
Expanding on Bayse and Rafferty’s work, I also used computational chemistry methods
to evaluate the potential halogen bonding interaction between iodine and selenium in the active
site of iodothyronine deiodinase. However, my analysis utilized the full deiodinase enzyme and
thyroxine ligand instead of truncated representations of each. Additionally, my investigation
strictly focused on the inactivating deiodinase, Dio3. I hypothesized that a halogen bonding
interaction was occurring in the active site of Dio3 between the inner ring 5-iodine and the
selenium. To test this hypothesis, I first needed to ensure that a significant s-hole existed on the
5-iodine. Then, I needed to put thyroxine in complex with Dio3 to evaluate the proximity and
geometry of the 5-iodine and the selenium atom.

Computational Methods
Thyroid Hormone Optimization
The geometries of the different forms of thyroid hormone were optimized using the
Gaussian 09 suite at the B3LYP level of theory.19 Harmonic vibrational frequency analyses were
completed in conjunction with the optimization at the B3LYP level of theory to ensure that the
optimized geometries corresponded to the lowest potential surface energy of the molecule.
Correlation-consistent triple-ζ (cc-pVTZ) basis sets were utilized for all atoms in thyroid
hormone except for iodine. For iodine, an energy-consistent pseudopotential from the
Stuttgart/Cologne was utilized to model the electrons of the atom.20
The quantitative analysis of the surface maxima of thyroid hormone was accomplished
using the wavefunction analyzer Multiwfn.21 A ”.wfn” output file was coded for in the route
section of the Gaussian input file. Surface maxima energy values corresponding to the different
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σ-holes were organized into an excel spreadsheet. Associated molecular pictures produced by
Multiwfn were included as reference to the quantitative data.
Electrostatic potential surfaces and HOMO-LUMOs of the different thyroid hormones
were visualized using GaussView 5.0.9.22 All potentials were computed on the 0.001 au
isodensity surface and visualized on a scale from -2.0e-2 to 2.0e-2 atomic units.

Protein Optimization
The PDB file 4TR3 was used as the starting point for Deiodinase type 3.23 However, the
crystal structure had to replace the typical selenocysteine with a cysteine during expression of the
protein. To get a true model of the protein, Cys170 was swapped for selenocysteine, and the
protein was computationally optimized using the ONIOM functionality from the Gaussian 09
suite. ONIOM stands for Our own N-layered Integrated molecular Orbital and molecular
Mechanics. This approach allows for the optimization of large systems, such as proteins, by
using a less computationally demanding method for the whole protein, referred to as the Low
Layer, and a more computationally demanding method for the area of interest, such as the active
site, referred to as the High Layer. The Low Layer in my calculation used the Amber molecular
mechanics method while the High Layer used the Hartree Fock method with a 6-31g(d) basis set.
The optimized protein was displayed using GaussView 5.0.9 with the High Layer in ball-andstick format and the Low Layer in wire format.

Docking Study
An open-source program called AutoDock Vina was used for the molecular docking
study.24 The Gaussian output files for both the protein and thyroxine had to be converted to a
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.pdb file and then to a .pdbqt file in order to be compatible with AutoDock Vina. A grid box was
centered around the active site with coordinates -9, -3, and 20 for the x, y, and z directions. The
size of the box was 22, 14, and 26 Å in the x, y, and z dimensions. AutoDock computed the
lowest energy conformation and produced a .pdb file that was analyzed using Pymol software.25

Sequence Alignment
NCBI Homologene was used to locate the Dio3 sequence in humans.26 NCBI BLAST
was then used to compare the Dio3 gene in humans to the Dio3 gene in mice.27 An alignment of
the two sequences was then performed using Clustal Omega.

Results and Significance
Dio3 Gene Sequence Alignment between Homo sapiens and Mus musculus
To investigate the similarities in the Dio3 proteins between humans and mice, I searched
for the Dio3 gene in NCBI’s Homologene system to locate the sequence in Homo sapiens. NCBI
BLAST provided that the Dio3 gene in mice is 95.05% identical to the gene in humans.
Additionally, I aligned the two sequences using Clustal Omega (Figure 6). Most importantly
from this analysis, the active site amino acids (S167, U170, E200, H202, H219, F258, and R275)
were conserved between the two species. The selenocysteine residues (U170) are highlighted in
yellow. The high degree of similarity between the two genes allows the analysis done on the
mouse protein to be extrapolated to the human protein.
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Figure 6. Dio3 protein sequence alignment between Homo sapiens and Mus musculus.
Sequences are 95.05% identical. Selenocysteine residue highlighted at the 170 positions in both
sequences.
σ-Hole Analysis on Thyroid Hormone
An analysis of the electrostatic surface potentials on thyroid hormone was performed to
investigate the size and strength of the σ-holes. The analysis consisted of generating qualitative
electrostatic surface potential maps (Figure 7) that reflect the quantitative data extracted from the
wavefunction file (Table 1).
The electrostatic surface potential map shows the existence of four different σ-holes on
thyroxine, each corresponding to one of the iodine atoms (Figure 7). Importantly, the inner ring
5-iodine atom, which is the target iodine for Dio3 deiodination, displays a significant positive
electrostatic potential 180° from the C-I bond, consistent with the identification of a σ-hole.
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Figure 7A and B. Electrostatic surface potential maps of thyroxine. Red indicates the areas
of most negative electrostatic potential and blue indicates areas of most positive electrostatic
potential. Each of the four iodine atoms have their own σ-hole. The target inner ring 5-iodine is
shown in A as the atom coming straight out of the page and in B on the bottom of the molecule.
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The quantitative results of the σ-hole analysis are provided in the form of a readout of the
wavefunction output file using the Multiwfn software. The software provides a graph of the
molecule with different points representing the local electrostatic potential minima and maxima
of the molecule (Figure 8). The numbers on the purple and red dots correspond to the data points
in the table produced by Multiwfn (Figure 9).
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Figure 8. Multiwfn output graph example. Purple dots indicate local electrostatic potential
minima and red dots indicate local electrostatic potential maxima. The target 5-iodine atom is
labeled as I34, and its corresponding electrostatic potential maximum is 13.

(rT3) (Table 1).
the σ-hole energy data for thyroxine (T4), triiodothyronine (T3), and reverse triiodothyronine
σ-holes are areas of positive electrostatic potential, so they are local maxima. I organized
Figure 9. Multiwfn output table example. Each of the points from the output graph has energy
and position data provided by the output table such as the one here. For the sake of my research,
I only used the kcal/mol energy values to be consistent with previous literature on σ-holes.
Tl8L9l.
0
9vccL9·0Z8L'cZ~·0

8l886L"
T6t'68~6"'c

~~6889"1

l8v8L'c"0

8l0l6L"
TL00v'c6"0-

~'c8t'00"0-

0t''c~zg·t;,-

69~vzz·~
996v6l.
0Lll'c~~-0
6nvsv
·0
0lL8E6.
TTLTUL"l669'c~~-0

'cL'cL08"0V0cc8T"l
lll9688"l
LL080E"088LT9v. l-

0c9c8v · LT
6886l8.
Ve
6l8LE6"ll
LTcvsT·v-

6V~9L~·z6'c6'c~L·0-

clL!llc·
L
Z'c'c~l~·v
Lc6898"l
6898TE"l
t'~6l0'c"Z
lvL60T"T
608l60"0
88llc0.
0

lll80v9"

'c'cZLLZ"T-

t'00'cl'c"6l

l6066T"T-

88866l"0
'clt'~60"0
9980lll"6T
"Tl
96lUL
86~861" 'c'c
TLv9Ec· Ll
vcL8lL"8T
ll0lc'c"lll
Tl
l6L8Tv"
v9ll80"'c'c

l'c9~0~-'c-

l6vL89"'c

T

t't'~L6l"'ccclll8L"lZ6~'cZZ"0
0TL'c6l"T8l8688.
E
6~6t''c8"Z

'c00Z'c0"T98898E"T
8lvv99·0l'cZ~t'0"l

(WOJlS8u~)aleUJpJOOJ

66l89l.

0-

8'c~8ll"ZllLL6c"
08lll8"
6L0L rn.
6~~0l'c"l
0z~gg~·'c
~t'66L9"'c
lLTEvL"

'cZ~88'c"Tl
T
E-

T-

8~t''cL~·1
8lllllv·0-

'c0~9'c0"Z
6L9'c~z·'cl8cLLT"T

~t'6z~9·1
E9vLsv·0LLv9rn · v
0L8T~z·'c
89v9ll"E886llc"
T
9vl09v"
T

'c80L~~-0
lUL6L"
89ll9T.
L8690L"T
l6T9l8.
L8l806"

lE-

0
T

(WOJlS8u~)aleUJpJOOJ

6t'Z~~L·zsv869L" vl09L98"vTL8T'c0"'cl0889l"9u6rnv·gcL9vLL"99lc9T'c"Lvl88LE · 6-

Z/A/X

v68l8T.
9
Z~Zt'~~-l
Ellll8v·T
06L98E"T
L0Llcv · T
8Z'c'c0~·0

~t'TZ86"'cL'c6t'L'c"~Z
T6TUv"
89LL6v.

Tl
0l

Z9'ct''c8"0

LL0Tv6·0
9l96cv·T
'c60t'6l"l
ccTns
·0
808E90"T
9088l6"0
l6~88'c"Z
TOW/TE>J)j
A•
:ew1xew
6T

Z8~~t'6"t'ZvTvcsv·60UL90"0T-

~t''ct'89"t'-

l~l660"T-

86llll.
vT90c68"9Tvsv000·s-

'c~LL0V"T-

t'Z'c066"L-

09cl8T"l0l8l06.
l-

'cl8Z~8·z08~L~~-'c-

8L6v0T"E
L898cc·l0LLL'c0"ll8Lllv·0l-

8l969l"908c9vv·6-

L6Z'c'c9"L'ct'09'c'c. vz-

Z/A/X

6lll8'cL"0
Z'c660~·1
L'c0l9~·0
scvrnT
· 0l89lLT
·009E00T"T
~9ll'c6"0
L98888"0
06vLE8"0
v00El0.
0
0vTv00·0

~6~t''c900"0-

~l

0cLEv0v0·0
896Hvrn
·0

VT
'cl
n

~Z~99Z'c0"0
llLLL0c0.
0
06LLv000"0
cllcrn00
·0
cll990E0.
0

l'cZ09t''c0"0
6Z~06Z~0·0
lll88Ev0.
vT9v86rn
llv606E0.

0
·0
0

66Z'clt''c0"0
0T6LLL80.
.n.e

aJE'fJns

0
fO

n
0T
6
8
L
9
c
v
E
l
T

"

Ja qwnN

8Z'c~L6'c0"096~ll~l0"0-

t'l
'cl

8L~9'ct'"0Z'cl'c0Z"0-

v6Ev09rn
· 0L6v9vL00·0vL908900"0L6El69l0"0Lc6varn
· 0-

n

8'c9Z'cL"0'c'c69t''c"0'c6t'9t''c"0vv9vcl

·0

~~6011·0'c'cZ680"08'cl~88"0ll0l'c'c"00l'c~~0·1VT

6T
8T
LT
9T

lvLT80"T9lETTv·0-

lllc8T"0-

TOW/TE>J)j

Elc98Ll0"0
8688vcc0·0
ULT90l0"0
cv899900"0-

n
0T
6
s

8'c'c'cLZl0"0-

L

608v6v00·0
lcLL0v00·09l6Llrn0·0-

9
c
v

ZZ8Z~Z'c0"0-

'c

lvv9lll0"0l6l8L8E0"0-

l
T

.n.e
:ew1u1w aJE'fJns

A•

fO

"

Ja qwnN

Rice 17

Rice 18
Table 1. Energy data for the σ-holes on T4, T3, and rT3.

Thyroid Hormone WFN Analysis
Atom
5-Iodine

Energy (kcal/mol)
(T4)
(T3)
(rT3)
21.47

19.20
20.22

5'-Iodine
3'-Iodine

20.50
25.37
17.49

14.85

15.42
20.34
27.52

Carboxyl Hydrogen
4'-Hydroxyl Hydrogen

55.08
34.82

54.85
53.50

52.26
37.92

3-Iodine

Interestingly, the strongest σ-hole on T4 is actually the outer ring 5’-iodine with an
energy value of 25.37 kcal/mol. However, the inner ring 5-iodine is the second strongest, with an
energy value of 21.47 kcal/mol. For comparison, I included the energy values for two different
hydrogens that would exhibit typical hydrogen bonding activity. The energy values for the
carboxyl hydrogen and the 4’-hydroxyl hydrogen are 55.08 kcal/mol and 34.82 kcal/mol,
respectively. Therefore, the relative interaction strength potential of the halogen bonds in this
molecule are roughly half that of typical hydrogen bonds. In summary, four different iodinecentered σ-holes exist on thyroxine, and the σ-hole at the 5-iodine position has significant
halogen bonding potential.

Optimization of Dio3 with Selenocysteine in Active Site
The PDB file 4TR3 provided the crystal structure of Dio3. However, the critical
selenocysteine residue in the active site was replaced with a typical cysteine residue by
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Schweizer et al. for expression and purification purposes. To obtain an accurate representation of
the true Dio3 enzyme, I replaced Cys170 with selenocysteine. Since I modified the chemical
identity of the PDB file, I needed to optimize the structure of the whole protein to get a reliable
representation of the protein with the selenocysteine residue in place. The optimization was done
using the ONIOM functionality from Gaussian 09 (see methods for more details on ONIOM).
After roughly two months of trial and error, the ONIOM job finished with a normal termination,
meaning that the program converged on a minimum energy structure for the protein containing
the selenocysteine residue. Optimized Dio3 has very similar secondary and tertiary structure
compared to the crystal structure provided by PDB file 4TR3. Both structures contain the core αhelices and β-sheets in roughly the same position (Figure 10).

Figure 10. Secondary and tertiary structure of 4TR3 and optimized Dio3. 4TR3 is shown on
the left and optimized Dio3 is shown on the right. The selenium and its hydrogen from the
selenocysteine residue are shown in the optimized Dio3 picture as the orange and grey spheres.
Visualization of the two proteins using Pymol’s cartoon format shows very similar secondary
and tertiary structure. In both structures, the five β-sheets in the middle of the protein are
sandwiched by three longer α-helices on the bottom of the protein and two shorter α-helices
towards the top.
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Figure 11. Optimized structure of Dio3 with selenocysteine. This visualization of the
optimized protein, provided by GaussView, shows the active site amino acids residues in Ball
and Stick format and the rest of the protein in Wire format. The selenium atom of the
selenocysteine residue is shown in orange.
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Docking Study with Thyroxine in Complex with Updated Dio3
The completion of the Dio3 optimization job allowed for the analysis of the position of
thyroxine in complex with Dio3. Using a program called Autodock Vina, I was able to find the
lowest energy binding conformation of thyroxine on Dio3. Autodock Vina placed thyroxine in
the active site binding cleft (Figure 12).

Figure 12. Thyroxine binding in active site pocket of Dio3. Optimized Dio3 is shown in the
Molecular Surface format and thyroxine is shown in Stick format. Thyroxine is shown binding in
the active site cleft of optimized Dio3 on the right side of the protein.
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AutoDock Vina decided that pointing the target 5-iodine towards the interior of the active
site was the lowest energy binding conformation (Figure 13). This is of great significance
because it confirmed that the ONIOM optimization of the protein was accurate, since Dio3
strictly performs inner ring deiodination at the 5-iodine position. If the location and conformation
of thyroxine was somewhere other than the active site, or not pointing the 5-iodine in the correct
position to undergo deiodination, then the reimplementation of the selenocysteine and
subsequent ONIOM optimization would be invalid.

Figure 13. Thyroxine conformation points 5-iodine to interior of enzyme. Using Pymol to
visualize, thyroxine, shown in Stick format, is oriented with the purple 5-iodine towards the
interior of the enzyme, which is shown in Wire format. The selenium atom is displayed as the
large orange sphere for reference.
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Zooming in on the target 5-iodine within the active site, it is apparent that the iodine is in
close relation to the selenium atom. However, for a halogen bonding interaction to exist, there
needs to be a 180° angle between the 5-iodine and the selenium. The 5-iodine is not directed at a
180° angle to the selenium and, therefore, I cannot conclude that there is a halogen bonding
interaction occurring in this scenario (Figure 14).
A

B

Rice 24
C

Figure 14 A, B, and C. Positioning of 5-iodine within Dio3 active site. Active site amino acids
are highlighted in green. Thyroxine is colored accordingly: carbon = cyan; iodine = purple;
oxygen = red; nitrogen = blue. The selenium atom is shown as the large orange sphere. (A) Faceon view of thyroxine complexed with Dio3. The 5-iodine is on the bottom of thyroxine and
pointed towards the middle of the active site. (B) Bird’s-eye view of thyroxine complexed with
Dio3. The 5-iodine is shown pointing into active site pocket. (C) Worm’s-eye view of thyroxine
complexed with Dio3. This view serves as the best perspective for visualizing the active site cleft
and position of 5-iodine in relation to the selenium. The 5-iodine is close in proximity to the
selenium but not pointing directly at the atom.

Dimerization and Removal of Phe258 Shield
While scanning the literature, I learned that Dio3 requires dimerization to become
activated. The crystal structure from PDB file 4TR3 represents the inactive monomeric form.
According to Schweizer et al., Phe258 acts as a shield that blocks any reactivity with the
selenium (Figure 15). Upon dimerization, the α2/β3-loop, which contains Phe258, relaxes, and
removes the Phe258 shield from the active site.
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Figure 15. Phe258 shield in active site. The Phe258 residue, shown in pink, blocks the
selenium atom, shown as the orange sphere, from the 5-iodine atom, shown in purple and
protruding into the active site. The other active site amino acids are shown in grey.
Removal of the Phe258 shield would open the possibility for a 180° angle between the
selenium and the 5-iodine. Additionally, Schweizer et al. alluded to the probability of His202
binding with the 4’-hydroxyl of thyroxine. With Arg275 already shown to be bound to the
carboxyl end of thyroxine, the removal of Phe258 from the active site by dimerization would
allow the 4’-hydroxyl of thyroxine to swing down and bind with His202 (Figure 16). Visualizing
in three dimensions, if the Phe258 shield was removed, and the carboxyl end and 4-hydroxyl of
thyroxine were bound to Arg275 and His202, respectively, then the 5-iodine and the selenium
would be interacting at a 180° angle.
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Figure 16. The potential for His202 to clamp thyroxine in the active site would put the 5iodine interacting with the selenium at a 180° angle. The carboxyl end of thyroxine was
already observed to bind to Arg275 from the docking study. If Phe258 was removed from the
active site, then the 4’-hydroxyl could bind to His202 and lock a roughly 180° angle between the
5-iodine and selenium.

Conclusion and Future Work
My data indicate that a halogen bonding interaction is unlikely to occur between the 5iodine and the selenium in the inactive monomeric state. Additionally, while I do suspect that a
halogen bonding interaction can occur in the active dimeric state, more computational analysis of
the dimeric state will be necessary to address this hypothesis. Future work on this project should
examine the conformation of thyroxine in the active site of Dio3 in the active dimeric state.
Approaching this question could be done in a couple of ways. The Phe258 residue could simply
be replaced by a less bulky amino acid, such as alanine, mimicking the conformational change
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that occurs with dimerization. This would remove the phenol group from the side chain, which
acts as the shield blocking access to selenium. The new Dio3 protein containing the F258A
mutation could be optimized using ONIOM, and a subsequent docking study could be run to
analyze the position of the 5-iodine in relation to the unguarded selenium. Alternatively, a
completely different approach could be utilized, such as Molecular Dynamics, to simulate the
true conformational changes observed with dimerization of Dio3. This approach would allow for
a more complete picture of the structure of Dio3 as a dimer rather than just altering one active
site amino acid residue to mimic the dimerization process.
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